Click here to get full coverage on BlackRock (NASDAQ: MIRM) Holds 3.47M Shares, 5.7% Stake - Stock Titan

BlackRock (NASDAQ: MIRM) Holds 3.47M Shares, 5.7% Stake  Stock Titan

BlackRock (NASDAQ: MIRM) Holds 3.47M Shares, 5.7% Stake - Stock Titan

Click here to get full coverage on MIRM Stock Price, Quote & Chart | MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) - ChartMill

MIRM Stock Price, Quote & Chart | MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM)  ChartMill

MIRM Stock Price, Quote & Chart | MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) - ChartMill

Click here to get full coverage on Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals Announces Primary Endpoint Met In Phase 2B Portion Of The Azure-1 Study - TradingView

Mirum Pharmaceuticals Announces Primary Endpoint Met In Phase 2B Portion Of The Azure-1 Study  TradingView

Mirum Pharmaceuticals Announces Primary Endpoint Met In Phase 2B Portion Of The Azure-1 Study - TradingView

Click here to get full coverage on Case Report: Mycoplasma pneumoniae-induced rash and mucositis (MIRM) in an 8-year-old girl: concise review of a challenging case. - Frontiers

Case Report: Mycoplasma pneumoniae-induced rash and mucositis (MIRM) in an 8-year-old girl: concise review of a challenging case.  Frontiers

Case Report: Mycoplasma pneumoniae-induced rash and mucositis (MIRM) in an 8-year-old girl: concise review of a challenging case. - Frontiers

Click here to get full coverage on Assessing Mirum Pharmaceuticals (MIRM) Valuation As Pivotal Trial Readouts And Hiring Plans Draw Fresh Attention - simplywall.st

Assessing Mirum Pharmaceuticals (MIRM) Valuation As Pivotal Trial Readouts And Hiring Plans Draw Fresh Attention  simplywall.st

Assessing Mirum Pharmaceuticals (MIRM) Valuation As Pivotal Trial Readouts And Hiring Plans Draw Fresh Attention - simplywall.st

Click here to get full coverage on Trading Systems Reacting to (MIRM) Volatility - Stock Traders Daily

Trading Systems Reacting to (MIRM) Volatility  Stock Traders Daily

Trading Systems Reacting to (MIRM) Volatility - Stock Traders Daily

Click here to get full coverage on Brelovitug shows high HDV response rates in Mirum (NASDAQ: MIRM) Phase 2b - Stock Titan

Brelovitug shows high HDV response rates in Mirum (NASDAQ: MIRM) Phase 2b  Stock Titan

Brelovitug shows high HDV response rates in Mirum (NASDAQ: MIRM) Phase 2b - Stock Titan

Click here to get full coverage on Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi‑Year Share Price Run? - Yahoo Finance

Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi‑Year Share Price Run?  Yahoo Finance

Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi‑Year Share Price Run? - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals (MIRM) Is Up 6.5% After First GAAP Profit And Higher Guidance - Has The Bull Case Changed? - simplywall.st

Mirum Pharmaceuticals (MIRM) Is Up 6.5% After First GAAP Profit And Higher Guidance - Has The Bull Case Changed?  simplywall.st

Mirum Pharmaceuticals (MIRM) Is Up 6.5% After First GAAP Profit And Higher Guidance - Has The Bull Case Changed? - simplywall.st

Click here to get full coverage on Mirum shows 100% virologic response in one hepatitis delta arm; Phase 3 due H2 - Stock Titan

Mirum shows 100% virologic response in one hepatitis delta arm; Phase 3 due H2  Stock Titan

Mirum shows 100% virologic response in one hepatitis delta arm; Phase 3 due H2 - Stock Titan

Click here to get full coverage on Mirum Pharmaceuticals (MIRM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Mirum Pharmaceuticals (MIRM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates  Yahoo Finance

Mirum Pharmaceuticals (MIRM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Click here to get full coverage on Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi Year Surge? - simplywall.st

Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi Year Surge?  simplywall.st

Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi Year Surge? - simplywall.st

Click here to get full coverage on Executive pay, board elections headline Mirum (NASDAQ: MIRM) 2026 proxy - Stock Titan

Executive pay, board elections headline Mirum (NASDAQ: MIRM) 2026 proxy  Stock Titan

Executive pay, board elections headline Mirum (NASDAQ: MIRM) 2026 proxy - Stock Titan

Click here to get full coverage on A Look At Mirum Pharmaceuticals (MIRM) Valuation After Volatile Trading On Common Stock Offering News - Yahoo Finance

A Look At Mirum Pharmaceuticals (MIRM) Valuation After Volatile Trading On Common Stock Offering News  Yahoo Finance

A Look At Mirum Pharmaceuticals (MIRM) Valuation After Volatile Trading On Common Stock Offering News - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals, Inc. (MIRM) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Yahoo Finance

Mirum Pharmaceuticals, Inc. (MIRM) Earnings Expected to Grow: What to Know Ahead of Q4 Release  Yahoo Finance

Mirum Pharmaceuticals, Inc. (MIRM) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Yahoo Finance

Click here to get full coverage on MIRM (NASDAQ: MIRM) files Rule 144: 2,000 shares via option exercise - Stock Titan

MIRM (NASDAQ: MIRM) files Rule 144: 2,000 shares via option exercise  Stock Titan

MIRM (NASDAQ: MIRM) files Rule 144: 2,000 shares via option exercise - Stock Titan

Click here to get full coverage on Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last? - Yahoo Finance

Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?  Yahoo Finance

Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on Should You Invest in Mirum Pharmaceuticals (MIRM)? - Yahoo Finance

Should You Invest in Mirum Pharmaceuticals (MIRM)?  Yahoo Finance

Should You Invest in Mirum Pharmaceuticals (MIRM)? - Yahoo Finance

Click here to get full coverage on A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Long Term Share Performance - Yahoo Finance

A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Long Term Share Performance  Yahoo Finance

A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Long Term Share Performance - Yahoo Finance

Click here to get full coverage on Mirum (MIRM) director uses options, sells 2,000 pre-planned shares - Stock Titan

Mirum (MIRM) director uses options, sells 2,000 pre-planned shares  Stock Titan

Mirum (MIRM) director uses options, sells 2,000 pre-planned shares - Stock Titan

Click here to get full coverage on CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick? - Yahoo Finance

CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick?  Yahoo Finance

CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick? - Yahoo Finance

Click here to get full coverage on How Investors May Respond To Mirum Pharmaceuticals (MIRM) Expanding Livmarli And Gaining J.P. Morgan Spotlight - Yahoo Finance

How Investors May Respond To Mirum Pharmaceuticals (MIRM) Expanding Livmarli And Gaining J.P. Morgan Spotlight  Yahoo Finance

How Investors May Respond To Mirum Pharmaceuticals (MIRM) Expanding Livmarli And Gaining J.P. Morgan Spotlight - Yahoo Finance

Click here to get full coverage on Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026? - Yahoo Finance

Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026?  Yahoo Finance

Will Strong Livmarli Uptake Continue to Aid MIRM's Revenues in 2026? - Yahoo Finance

Click here to get full coverage on Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report? - Yahoo Finance

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?  Yahoo Finance

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report? - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals (MIRM) Completes Enrollment for Phase 3 EXPAND Study of LIVMARLI - Yahoo Finance

Mirum Pharmaceuticals (MIRM) Completes Enrollment for Phase 3 EXPAND Study of LIVMARLI  Yahoo Finance

Mirum Pharmaceuticals (MIRM) Completes Enrollment for Phase 3 EXPAND Study of LIVMARLI - Yahoo Finance

Click here to get full coverage on 12 Mirum hires get stock options and RSUs in April 10 grant - Stock Titan

12 Mirum hires get stock options and RSUs in April 10 grant  Stock Titan

12 Mirum hires get stock options and RSUs in April 10 grant - Stock Titan

Click here to get full coverage on Mirum (MIRM) details Bluejay deal and $268.5M PIPE financing - Stock Titan

Mirum (MIRM) details Bluejay deal and $268.5M PIPE financing  Stock Titan

Mirum (MIRM) details Bluejay deal and $268.5M PIPE financing - Stock Titan

Click here to get full coverage on Mirum’s brelovitug succeeds in Phase 2b HDV trial - TipRanks

Mirum’s brelovitug succeeds in Phase 2b HDV trial  TipRanks

Mirum’s brelovitug succeeds in Phase 2b HDV trial - TipRanks

Click here to get full coverage on Mirum Pharmaceuticals Stock Drops 15% After Share Offering. Analysts Still Target $120 - TIKR.com

Mirum Pharmaceuticals Stock Drops 15% After Share Offering. Analysts Still Target $120  TIKR.com

Mirum Pharmaceuticals Stock Drops 15% After Share Offering. Analysts Still Target $120 - TIKR.com

Click here to get full coverage on Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected To Breakeven In The Medium-Term - Yahoo Finance

Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected To Breakeven In The Medium-Term  Yahoo Finance

Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected To Breakeven In The Medium-Term - Yahoo Finance

Click here to get full coverage on Subdued Growth No Barrier To Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) With Shares Advancing 25% - simplywall.st

Subdued Growth No Barrier To Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) With Shares Advancing 25%  simplywall.st

Subdued Growth No Barrier To Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) With Shares Advancing 25% - simplywall.st

Click here to get full coverage on Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $130 - Moomoo

Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $130  Moomoo

Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $130 - Moomoo

Click here to get full coverage on How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing - Stock Traders Daily

How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing  Stock Traders Daily

How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing - Stock Traders Daily

Click here to get full coverage on 18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC - MarketBeat

18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC  MarketBeat

18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC - MarketBeat

Click here to get full coverage on Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings? - qz.com

Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?  qz.com

Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings? - qz.com

Click here to get full coverage on Mirum (MIRM) Q1 2025 Earnings Call Transcript - AOL.com

Mirum (MIRM) Q1 2025 Earnings Call Transcript  AOL.com

Mirum (MIRM) Q1 2025 Earnings Call Transcript - AOL.com

Click here to get full coverage on Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM) - Seeking Alpha

Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)  Seeking Alpha

Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM) - Seeking Alpha

Click here to get full coverage on Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Q4 2025 Revenue Beat and 2026 Outlook - ChartMill

Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Q4 2025 Revenue Beat and 2026 Outlook  ChartMill

Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Q4 2025 Revenue Beat and 2026 Outlook - ChartMill

Click here to get full coverage on Is Mirum Pharmaceuticals (MIRM) stock trading at a discount | Q4 2025: EPS Misses Estimates - Customer Loyalty - Cổng thông tin điện tử Tỉnh Sơn La

Is Mirum Pharmaceuticals (MIRM) stock trading at a discount | Q4 2025: EPS Misses Estimates - Customer Loyalty  Cổng thông tin điện tử Tỉnh Sơn La

Is Mirum Pharmaceuticals (MIRM) stock trading at a discount | Q4 2025: EPS Misses Estimates - Customer Loyalty - Cổng thông tin điện tử Tỉnh Sơn La

Click here to get full coverage on Baird Lifts Mirum Pharmaceuticals, Inc. (MIRM) Price Target on Bluejay Therapeutics Acquisition - Yahoo Finance

Baird Lifts Mirum Pharmaceuticals, Inc. (MIRM) Price Target on Bluejay Therapeutics Acquisition  Yahoo Finance

Baird Lifts Mirum Pharmaceuticals, Inc. (MIRM) Price Target on Bluejay Therapeutics Acquisition - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals (MIRM) Up 1.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mirum Pharmaceuticals (MIRM) Up 1.3% Since Last Earnings Report: Can It Continue?  Yahoo Finance

Mirum Pharmaceuticals (MIRM) Up 1.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals (MIRM): Discounted Valuation Reinforces Bullish Narrative on Profit Breakthrough Potential - Yahoo Finance

Mirum Pharmaceuticals (MIRM): Discounted Valuation Reinforces Bullish Narrative on Profit Breakthrough Potential  Yahoo Finance

Mirum Pharmaceuticals (MIRM): Discounted Valuation Reinforces Bullish Narrative on Profit Breakthrough Potential - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Offers a High-Growth Momentum and Technical Breakout Setup - ChartMill

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Offers a High-Growth Momentum and Technical Breakout Setup  ChartMill

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Offers a High-Growth Momentum and Technical Breakout Setup - ChartMill

Click here to get full coverage on Rare disease drugmaker plans more liver and Fragile X trials after sales jump - Stock Titan

Rare disease drugmaker plans more liver and Fragile X trials after sales jump  Stock Titan

Rare disease drugmaker plans more liver and Fragile X trials after sales jump - Stock Titan

Click here to get full coverage on Rare disease company Mirum joins J.P. Morgan health conference lineup in SF - Stock Titan

Rare disease company Mirum joins J.P. Morgan health conference lineup in SF  Stock Titan

Rare disease company Mirum joins J.P. Morgan health conference lineup in SF - Stock Titan

Click here to get full coverage on New Mirum staff get stock grants, some tied to 2027–28 net sales - Stock Titan

New Mirum staff get stock grants, some tied to 2027–28 net sales  Stock Titan

New Mirum staff get stock grants, some tied to 2027–28 net sales - Stock Titan

Click here to get full coverage on Mirum (MIRM) Q4 2025 Earnings Call Transcript - AOL.com

Mirum (MIRM) Q4 2025 Earnings Call Transcript  AOL.com

Mirum (MIRM) Q4 2025 Earnings Call Transcript - AOL.com

Click here to get full coverage on MIRM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

MIRM Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

MIRM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Embodies the Minervini Growth Momentum Strategy - ChartMill

MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Embodies the Minervini Growth Momentum Strategy  ChartMill

MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Embodies the Minervini Growth Momentum Strategy - ChartMill

Click here to get full coverage on H.C. Wainwright Raises PT on Mirum Pharmaceuticals For the Second Time In a Span of Two Weeks, Here is Why? - Yahoo Finance

H.C. Wainwright Raises PT on Mirum Pharmaceuticals For the Second Time In a Span of Two Weeks, Here is Why?  Yahoo Finance

H.C. Wainwright Raises PT on Mirum Pharmaceuticals For the Second Time In a Span of Two Weeks, Here is Why? - Yahoo Finance

Click here to get full coverage on Vanguard disaggregates holdings; Mirum (MIRM) shows 0 shares owned - Stock Titan

Vanguard disaggregates holdings; Mirum (MIRM) shows 0 shares owned  Stock Titan

Vanguard disaggregates holdings; Mirum (MIRM) shows 0 shares owned - Stock Titan

Click here to get full coverage on Rare liver disease trial of Mirum itch drug finishes signup - Stock Titan

Rare liver disease trial of Mirum itch drug finishes signup  Stock Titan

Rare liver disease trial of Mirum itch drug finishes signup - Stock Titan

Click here to get full coverage on (MIRM) and the Role of Price-Sensitive Allocations - Stock Traders Daily

(MIRM) and the Role of Price-Sensitive Allocations  Stock Traders Daily

(MIRM) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Click here to get full coverage on Mirum Pharmaceuticals (Nasdaq: MIRM) approves stock option and RSU inducement grants for 8 new hires - Stock Titan

Mirum Pharmaceuticals (Nasdaq: MIRM) approves stock option and RSU inducement grants for 8 new hires  Stock Titan

Mirum Pharmaceuticals (Nasdaq: MIRM) approves stock option and RSU inducement grants for 8 new hires - Stock Titan

Click here to get full coverage on Mirum Pharmaceuticals gives stock to new hires as they join the company - Stock Titan

Mirum Pharmaceuticals gives stock to new hires as they join the company  Stock Titan

Mirum Pharmaceuticals gives stock to new hires as they join the company - Stock Titan

Click here to get full coverage on Mirum Pharmaceuticals (NASDAQ:MIRM) Is Carrying A Fair Bit Of Debt - simplywall.st

Mirum Pharmaceuticals (NASDAQ:MIRM) Is Carrying A Fair Bit Of Debt  simplywall.st

Mirum Pharmaceuticals (NASDAQ:MIRM) Is Carrying A Fair Bit Of Debt - simplywall.st

Click here to get full coverage on Mirum Pharmaceuticals (NASDAQ: MIRM) files to sell 7,287 vested RSU shares - Stock Titan

Mirum Pharmaceuticals (NASDAQ: MIRM) files to sell 7,287 vested RSU shares  Stock Titan

Mirum Pharmaceuticals (NASDAQ: MIRM) files to sell 7,287 vested RSU shares - Stock Titan

Click here to get full coverage on Saira Ramasastry to sell 2,000 shares via option exercise (NASDAQ: MIRM) - Stock Titan

Saira Ramasastry to sell 2,000 shares via option exercise (NASDAQ: MIRM)  Stock Titan

Saira Ramasastry to sell 2,000 shares via option exercise (NASDAQ: MIRM) - Stock Titan

Click here to get full coverage on Mirum Pharmaceuticals (MIRM) files Form 144: proposed resale of vested RSUs - Stock Titan

Mirum Pharmaceuticals (MIRM) files Form 144: proposed resale of vested RSUs  Stock Titan

Mirum Pharmaceuticals (MIRM) files Form 144: proposed resale of vested RSUs - Stock Titan

Click here to get full coverage on MIRM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

MIRM Financials: Revenue Breakdown, Margins & Competitor Comparison  Intellectia AI

MIRM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Click here to get full coverage on Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 11.25% Upside Potential - DirectorsTalk Interviews

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 11.25% Upside Potential  DirectorsTalk Interviews

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 11.25% Upside Potential - DirectorsTalk Interviews

Click here to get full coverage on Mirum (MIRM) CEO sells shares to cover tax from RSU vesting - Stock Titan

Mirum (MIRM) CEO sells shares to cover tax from RSU vesting  Stock Titan

Mirum (MIRM) CEO sells shares to cover tax from RSU vesting - Stock Titan

Click here to get full coverage on What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now - Yahoo Finance

What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now  Yahoo Finance

What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now - Yahoo Finance

Click here to get full coverage on Mirum Pharmaceuticals (NASDAQ: MIRM) insider plans 968-share stock sale - Stock Titan

Mirum Pharmaceuticals (NASDAQ: MIRM) insider plans 968-share stock sale  Stock Titan

Mirum Pharmaceuticals (NASDAQ: MIRM) insider plans 968-share stock sale - Stock Titan

Click here to get full coverage on CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? - Yahoo Finance

CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy?  Yahoo Finance

CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? - Yahoo Finance

Click here to get full coverage on Mirum Completes Enrollment & Screening in Liver Disease Studies - Zacks Investment Research

Mirum Completes Enrollment & Screening in Liver Disease Studies  Zacks Investment Research

MIRM

Price Chart

Key Statistics

Technicals

About MIRM

Latest News

BlackRock (NASDAQ: MIRM) Holds 3.47M Shares, 5.7% Stake - Stock Titan

MIRM Stock Price, Quote & Chart | MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) - ChartMill

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers